In accordance with section 38 and 39 of the Danish Capital Markets Act, ChemoMetec has received information that the following shareholders hold 5% or more of the company’s share capital:
- SEB Investment Management AB / SEBinvest A/S
- BlackRock, Inc. (more than 10%)